-
1
-
-
84893930312
-
Survivin as a preferential target for cancer therapy
-
24531137,; PMID:,; http://dx.doi.org/
-
Mobahat M, Narendran A, Riabowol K. Survivin as a preferential target for cancer therapy. Inter J Mol Sci 2014; 15:2494-516; PMID:24531137; http://dx.doi.org/10.3390/ijms15022494
-
(2014)
Inter J Mol Sci
, vol.15
, pp. 2494-2516
-
-
Mobahat, M.1
Narendran, A.2
Riabowol, K.3
-
2
-
-
0034598797
-
High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma
-
10698506,; PMID:,; http://dx.doi.org/
-
Islam A, Kageyama H, Takada N, Kawamoto T, Takayasu H, Isogai E, Ohira M, Hashizume K, Kobayashi H, Kaneko Y, et al. High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene 2000; 19:617-23; PMID:10698506; http://dx.doi.org/10.1038/sj.onc.1203358
-
(2000)
Oncogene
, vol.19
, pp. 617-623
-
-
Islam, A.1
Kageyama, H.2
Takada, N.3
Kawamoto, T.4
Takayasu, H.5
Isogai, E.6
Ohira, M.7
Hashizume, K.8
Kobayashi, H.9
Kaneko, Y.10
-
3
-
-
65249166592
-
Repression of BIRC5/survivin by FOXO3/FKHRL1 sensitizes human neuroblastoma cells to DNA damage-induced apoptosis
-
19211844,; PMID:,; http://dx.doi.org/
-
Obexer P, Hagenbuchner J, Unterkircher T, Sachsenmaier N, Seifarth C, Bock G, Porto V, Geiger K, Ausserlechner M. Repression of BIRC5/survivin by FOXO3/FKHRL1 sensitizes human neuroblastoma cells to DNA damage-induced apoptosis. Mol Biol Cell 2009; 20:2041-8; PMID:19211844; http://dx.doi.org/10.1091/mbc.E08-07-0699
-
(2009)
Mol Biol Cell
, vol.20
, pp. 2041-2048
-
-
Obexer, P.1
Hagenbuchner, J.2
Unterkircher, T.3
Sachsenmaier, N.4
Seifarth, C.5
Bock, G.6
Porto, V.7
Geiger, K.8
Ausserlechner, M.9
-
4
-
-
4544261227
-
An IAP-IAP complex inhibits apoptosis
-
15218035,; PMID:,; http://dx.doi.org/
-
Dohi T, Okada K, Xia F, Wilford CE, Samuel T, Welsh K, Marusawa H, Zou H, Armstrong R, Matsuzawa S, et al. An IAP-IAP complex inhibits apoptosis. J Biol Chem 2004; 279: 34087-90; PMID:15218035; http://dx.doi.org/10.1074/jbc.C400236200
-
(2004)
J Biol Chem
, vol.279
, pp. 34087-34090
-
-
Dohi, T.1
Okada, K.2
Xia, F.3
Wilford, C.E.4
Samuel, T.5
Welsh, K.6
Marusawa, H.7
Zou, H.8
Armstrong, R.9
Matsuzawa, S.10
-
5
-
-
84885178346
-
Ausserlechner MJ. BIRC5/Survivin enhances aerobic glycolysis and drug resistance by altered regulation of the mitochondrial fusion/fission machinery
-
23146905,; PMID:,; http://dx.doi.org/
-
Hagenbuchner J, Kuznetsov AV, Obexer P, Ausserlechner MJ. BIRC5/Survivin enhances aerobic glycolysis and drug resistance by altered regulation of the mitochondrial fusion/fission machinery. Oncogene 2013; 32: 4748-57; PMID:23146905; http://dx.doi.org/10.1038/onc.2012.500
-
(2013)
Oncogene
, vol.32
, pp. 4748-4757
-
-
Hagenbuchner, J.1
Kuznetsov, A.V.2
Obexer, P.3
-
6
-
-
84884557400
-
Mitochondria and FOXO3: Breath or Die
-
23801966,; PMID:,; http://dx.doi.org/
-
Hagenbuchner J, Ausserlechner MJ. Mitochondria and FOXO3: Breath or Die. Frontiers in Physiology 2013; 4; PMID:23801966; http://dx.doi.org/10.3389/fphys.2013.00147
-
(2013)
Frontiers in Physiology
, vol.4
-
-
Hagenbuchner, J.1
Ausserlechner, M.J.2
-
7
-
-
0036347515
-
Lactate stimulates fibroblast expression of hyaluronan and CD44: the Warburg effect revisited
-
11978005,; PMID:,; http://dx.doi.org/
-
Stern R, Shuster S, Neudecker BA, Formby B. Lactate stimulates fibroblast expression of hyaluronan and CD44: the Warburg effect revisited. Exp Cell Res 2002; 276: 24-31; PMID:11978005; http://dx.doi.org/10.1006/excr.2002.5508
-
(2002)
Exp Cell Res
, vol.276
, pp. 24-31
-
-
Stern, R.1
Shuster, S.2
Neudecker, B.A.3
Formby, B.4
-
9
-
-
84879138893
-
Selective escape of proteins from the mitochondria during mitophagy
-
23361001,;PMID:,; http://dx.doi.org/
-
Saita S, Shirane M, Nakayama KI. Selective escape of proteins from the mitochondria during mitophagy. Nat Commun 2013; 4: 1410;PMID:23361001; http://dx.doi.org/10.1038/ncomms2400
-
(2013)
Nat Commun
, vol.4
, pp. 1410
-
-
Saita, S.1
Shirane, M.2
Nakayama, K.I.3
|